NVIDIA BioNemo for Linux contains a vulnerability where a user could cause a deserialization of untrusted data
Description
NVIDIA BioNemo for Linux contains a vulnerability where a user could cause a deserialization of untrusted data
AI Analyst Comment
Remediation
Apply vendor security updates immediately. Monitor for exploitation attempts and review access logs.
---METADATA---
VENDOR: NVIDIA
PRODUCT: BioNemo
AFFECTED_VERSIONS: See vendor advisory for specific affected versions
CONFIDENCE: medium
MISSING: versions, patch, technical_details
---END_METADATA---
Description Summary:
NVIDIA BioNemo for Linux is susceptible to a deserialization of untrusted data, which could lead to unauthorized code execution or system compromise.
Executive Summary:
A deserialization vulnerability in NVIDIA BioNemo for Linux poses a significant risk of remote code execution if left unpatched.
Vulnerability Details
CVE-ID: CVE-2026-24216
Affected Software: NVIDIA BioNemo
Affected Versions: See vendor advisory for specific affected versions
Vulnerability: This vulnerability involves the improper deserialization of untrusted data within the BioNemo framework. An authenticated user could potentially leverage this flaw to execute arbitrary code or manipulate application logic.
Business Impact
With a CVSS score of 7.8, this vulnerability represents a high-severity risk to organizational infrastructure. Successful exploitation could result in full system compromise, unauthorized data access, or the disruption of critical research workflows managed by BioNemo.
Remediation Plan
Immediate Action: Monitor NVIDIA’s security portal for the release of an official patch and apply it to all BioNemo deployments immediately upon availability.
Proactive Monitoring: Inspect system logs for unusual process execution patterns or unexpected deserialization errors that may indicate an exploitation attempt.
Compensating Controls: Restrict access to BioNemo instances to authorized personnel only and ensure the application runs with the minimum necessary privileges to limit the impact of a potential compromise.
Exploitation Status
Public Exploit Available: false
Analyst Notes: As of May 21, 2026, there is no public information indicating active exploitation of this vulnerability. However, due to the nature of the flaw, the potential for exploitation is high.
Analyst Recommendation
Given the severity of this deserialization flaw, administrators must prioritize the identification of affected BioNemo instances. Ensure that security teams are subscribed to NVIDIA security notifications to facilitate the rapid deployment of patches as soon as they are published.